RED LIGHT HOLLAND CORP. (4YX) - Net Assets
Based on the latest financial reports, RED LIGHT HOLLAND CORP. (4YX) has net assets worth €18.04 Million EUR (≈ $21.09 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€21.86 Million ≈ $25.56 Million USD) and total liabilities (€3.82 Million ≈ $4.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check RED LIGHT HOLLAND CORP. (4YX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €18.04 Million |
| % of Total Assets | 82.51% |
| Annual Growth Rate | -21.24% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 9.77 |
RED LIGHT HOLLAND CORP. - Net Assets Trend (2022–2026)
This chart illustrates how RED LIGHT HOLLAND CORP.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of RED LIGHT HOLLAND CORP..
Annual Net Assets for RED LIGHT HOLLAND CORP. (2022–2026)
The table below shows the annual net assets of RED LIGHT HOLLAND CORP. from 2022 to 2026. Also explore 4YX shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | €11.22 Million ≈ $13.12 Million |
-35.33% |
| 2025-03-31 | €17.35 Million ≈ $20.28 Million |
-14.38% |
| 2024-03-31 | €20.26 Million ≈ $23.69 Million |
-23.08% |
| 2023-03-31 | €26.34 Million ≈ $30.80 Million |
-9.65% |
| 2022-03-31 | €29.16 Million ≈ $34.09 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to RED LIGHT HOLLAND CORP.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2316964800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €60.27 Million | 503.65% |
| Total Equity | €11.97 Million | 100.00% |
RED LIGHT HOLLAND CORP. Competitors by Market Cap
The table below lists competitors of RED LIGHT HOLLAND CORP. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gresham House Energy Storage Fund PLC
LSE:GRID
|
$6.62 Million |
|
AbleGroup Bhd
KLSE:7086
|
$6.63 Million |
|
Shanghai Taihe Water Environmental Technology Development Co Ltd
SHG:605081
|
$6.63 Million |
|
Silynxcom Ltd.
NYSE MKT:SYNX
|
$6.63 Million |
|
Sakol Energy Public Company Limited
BK:SKE
|
$6.61 Million |
|
Equinox Resources Ltd
AU:EQN
|
$6.61 Million |
|
Henderson Smaller Cos Inv Tst
LSE:HSL
|
$6.61 Million |
|
JPMorgan Global Emerging Markets Investment Trust PLC
LSE:JEMI
|
$6.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RED LIGHT HOLLAND CORP.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 17,352,380 to 11,966,082, a change of -5,386,298 (-31.0%).
- Net loss of 6,101,998 reduced equity.
- Other factors increased equity by 715,700.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-6.10 Million | -50.99% |
| Other Changes | €715.70K | +5.98% |
| Total Change | €- | -31.04% |
Book Value vs Market Value Analysis
This analysis compares RED LIGHT HOLLAND CORP.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.34x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.12x to 0.34x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | €0.08 | €0.01 | x |
| 2023-03-31 | €0.07 | €0.01 | x |
| 2024-03-31 | €0.05 | €0.01 | x |
| 2025-03-31 | €0.04 | €0.01 | x |
| 2026-03-31 | €0.03 | €0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RED LIGHT HOLLAND CORP. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -50.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -145.45%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.22x
- Recent ROE (-50.99%) is below the historical average (-36.69%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -50.45% | -617.78% | 0.07x | 1.16x | €-17.21 Million |
| 2023 | -20.71% | -136.67% | 0.13x | 1.16x | €-8.00 Million |
| 2024 | -38.00% | -160.51% | 0.20x | 1.20x | €-9.63 Million |
| 2025 | -23.29% | -81.75% | 0.23x | 1.22x | €-5.78 Million |
| 2026 | -50.99% | -145.45% | 0.29x | 1.22x | €-7.30 Million |
Industry Comparison
This section compares RED LIGHT HOLLAND CORP.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,136,804,231
- Average return on equity (ROE) among peers: -26.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RED LIGHT HOLLAND CORP. (4YX) | €18.04 Million | -50.45% | 0.21x | $6.62 Million |
| SHANG.FOS.PHARM.GR.H YC 1 (08HH) | $48.38 Billion | 9.77% | 0.93x | $1.20 Billion |
| PEPTONIC MEDICAL (28L) | $38.24 Million | -58.82% | 0.72x | $5.52 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $7.85 Billion | 28.40% | 0.37x | $692.11 Million |
| WEST ISLAND BRANDS INC. (39N0) | $3.27 Million | -157.21% | 0.88x | $1.34 Million |
| HANSOH PHARMAC. HD-00001 (3KY) | $25.79 Billion | 12.71% | 0.28x | $22.06 Billion |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $4.89 Million | -63.10% | 0.49x | $97.35K |
| CERENO SCIENTIFIC AB B (4A1) | $170.06 Million | -9.56% | 0.06x | $123.09 Million |
| MAPLE LEAF GREEN WORLD (4HV0) | $-8.51 Million | 0.00% | 0.00x | $504.30K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-1.01 Million | 0.00% | 0.00x | $134.78K |
About RED LIGHT HOLLAND CORP.
Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. Its products… Read more